MedTrace Logo

Localized Analysis of Normalized Distance From Scalp to Cortex and Personalized Evaluation (LANDSCAPE)

NCT05967390 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 488

Last updated 2025-01-14

No results posted yet for this study

Summary

Scalp to cortex distance (SCD), as a key technological parameter of brain stimulation, has been highlighted in the guidelines of non-invasive brain stimulation. However, in the context of age-related brain changes, the region-specific SCD and its impact on stimulation-induced electric field in different types of neurodegenerative diseases remain unclear.

Conditions

  • Aging
  • Dementia Alzheimers
  • Parkinson Disease
  • Dementia Frontotemporal
  • Depression in Old Age

Interventions

DEVICE

Transcranial Magnetic Stimulation

One time for each day, lasting for three weeks.

Sponsors & Collaborators

  • Chinese University of Hong Kong

    lead OTHER

Principal Investigators

  • Hanna LU, PhD · Chinese University of Hong Kong

Eligibility

Min Age
60 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-15
Primary Completion
2024-12-14
Completion
2025-06-14
FDA Device
Yes

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05967390 on ClinicalTrials.gov